What Schooner Capital does

Schooner Capital is a Boston-based private investment firm founded in 1971 by Vin Ryan, operating from a permanent, evergreen capital base with no external fundraising obligations or LP-driven mandate constraints. The firm invests across both private companies and public securities, focusing on technology, healthcare, and services companies at all stages, and describes its portfolio as "highly concentrated." Schooner's private investing efforts center on building long-term partnerships with CEOs and management teams — taking board or observer seats at portfolio companies such as Brixton Biosciences, SRS Medical, Amplified Industries, Censinet, Kewazo, Commonwealth Fusion Systems, Breezeway, MarginEdge, and Onebeat — while its public equity book is global in scope and concentrated in leading companies with exceptional teams. The firm's recent disclosed venture activity includes leading a $20M Series C in Mantle (metal 3D printing, July 2024), a $15M round in Onebeat (inventory optimization, May 2025), a $35M Series A in Kewazo (construction robotics, March 2026), and participating in Manna Air Delivery's $50M Series B (autonomous drone delivery, April 2026).

Notable historical outcomes include growing Iron Mountain from a single storage site into a $30B+ global records management company, and exits such as Seventh Generation (Unilever), 4G Clinical (Goldman Sachs Asset Management), Best Doctors, Mimetogen Pharmaceuticals (Allergan), Continental Cablevision (sold 1996), StyleFeeder, Topokine Therapeutics, Zixi, and MediaSilo. The firm operates from a single headquarters at Two Financial Center, 60 South Street, 11th Floor, Boston, MA, with a team of approximately 16 professionals including Managing Partners, Directors, Associates, and operations staff. Schooner also operates The Schooner Foundation, founded in 1996 by Vin Ryan, which manages more than eighty global grantmaking partnerships focused on human rights, social justice, global health equity, education, economic empowerment, and environmental resilience; the Foundation is operationally integrated with the investment firm and shares back-office staff.

The firm's business model rests on long-term capital appreciation across its private and public positions rather than fee-based revenue; it sources opportunities through direct relationships cultivated over five decades, and its permanent capital base allows repeat investments in the same holdings across cycles. Technology is not a core operating competency — Schooner is an allocator, not a builder — and the firm has no proprietary software, app, API, or product surface of its own. Revenue is not publicly disclosed, and as an evergreen entity Schooner has no traditional LP base, fund vintages, or management-fee streams, distinguishing it structurally from conventional private equity or venture capital firms.

Name

Schooner Capital

Legal name

Schooner Capital LLC

Website

https://schoonercapital.com

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

11–50 employees

Short description

Schooner Capital is a Boston-based private investment firm founded in 1971, deploying permanent evergreen capital into concentrated positions across private companies and public securities in technology, healthcare, and services sectors. It partners directly with management teams and also operates the philanthropic Schooner Foundation.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Technology or R&D

Revenue model

1. Investment Returns: Returns from successful portfolio company exits and public equity appreciation
2. Investment Management: Long-term capital appreciation through private and public market investments

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Schooner Capital is a private investment firm that deploys permanent, evergreen capital into private companies and publicly traded securities across technology, healthcare, and services. The firm takes concentrated, long-term positions, often investing multiple times in the same holding, and partners directly with management teams rather than running external fund mandates.

Product overview

Schooner Capital is a private investment firm established in 1971, investing in private companies and public securities from a permanent capital base. The firm focuses on technology, healthcare, and services companies at all stages. Schooner Capital operates across private and public markets with a concentrated portfolio approach, building long-term positions in investments. The firm's private investment efforts focus on working closely with CEOs and leadership teams to build businesses, while public investments are global in scope and highly concentrated in leading companies with exceptional teams.

Differentiator

Problem solved

Functional benefit

Brands

• The Schooner Foundation: Philanthropic foundation supporting human rights, social justice, global health equity, education, economic empowerment, and environmental causes. Founded in 1996 by Vin Ryan.

Products and services

• Private Direct Investments Long-term equity capital and strategic partnership provided directly to private operating companies in technology, healthcare, and services across stages. Available to founder- and management-led teams seeking patient capital.
• Direct Public Equity Investing Program Global, highly concentrated direct public equity strategy targeting leading public companies with exceptional management teams. Built and grown internally at Schooner.
• The Schooner Foundation Grantmaking Invitation-only philanthropic grantmaking program supporting not-for-profit causes globally across human rights, social justice, global health equity, education, economic empowerment, and the environment. Managed under a separate Foundation entity.

Quantifiable outcome

• Iron Mountain grew from a single storage site to a $30+ billion global records management company under Schooner ownership
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Iconiq Capital: Multi-family office and private investment firm with permanent capital that invests in technology, healthcare, and growth-stage companies alongside founders. Highly comparable in evergreen structure, sector focus, and concentrated approach.
• Bezos Expeditions: Personal investment vehicle of Jeff Bezos making concentrated, long-duration bets in technology and adjacent sectors. Comparable as evergreen family capital deployed opportunistically.
• Patient Capital Management: Early-to-growth stage evergreen fund applying patient, multi-cycle capital to technology and healthcare companies. Closely aligned with Schooner's long-duration, no-mandate philosophy.
• Vulcan Capital: Permanent-capital investment vehicle that deploys across private and public markets with a long horizon. Comparable as an evergreen, multi-strategy allocator not bound by fund life.
• Allen & Company: Privately held investment bank and principal investor with deep, decades-long relationships and a permanent capital base. Similar in its concentrated approach and founder-led independence.

Broad incumbents

• Maverick Capital: Long-tenured, multi-strategy investment firm combining public equities with selective private investments. Comparable in patient, concentrated approach across public and private markets.
• Bain Capital: Large multi-strategy alternative asset manager with venture, growth, and healthcare investing arms. Comparable as a Boston-based investor in similar sectors, though at significantly greater scale.

Emerging players

• Khosla Ventures: Venture firm deploying capital across technology, healthcare, and sustainability stages with a long-duration, high-conviction approach. Comparable in sector breadth and willingness to lead concentrated positions.
• General Catalyst: Multi-stage investor with deep healthcare and technology franchises and a long-duration, founder-friendly orientation. Comparable in sector focus and willingness to lead concentrated growth rounds.
• GreatPoint Ventures: Boston-based venture firm investing in technology and healthcare with concentrated positions and long-duration capital. Comparable in geography, sector focus, and concentrated style.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/schooner-capital
• Xx.com/schoonercapital
• Facebookfacebook.com/schoonercapital

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments75 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schooner Capital